Laborie Medical Technologies

Laborie Medical Technologies is a global developer, manufacturer, and marketer of advanced medical technologies and consumables focused on diagnosing and treating urinary and fecal incontinence, as well as other pelvic floor disorders. The company specializes in diagnostic and therapeutic equipment for urology, urogynecology, and gastroenterology, providing solutions that include urodynamic testing to identify the causes of urinary incontinence. Laborie's innovative product offerings aim to address the needs of healthcare providers and improve patient outcomes in managing pelvic floor and gastrointestinal disorders.

Nikki Bruce

Vice President, Global OB Business Segment

10 past transactions

Vensica Medical

Venture Round in 2021
Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%). Using Vensica’s device, the drug will be instilled in a quick, pain-free procedure subsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.

Clinical Innovations

Acquisition in 2019
Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery. Already a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter and Kiwi® Vacuum-Assisted Delivery System, Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Since its inception in 1993, Clinical Innovations has consistently expanded its worldwide presence, becoming the market leader in several product categories. This growth has fueled the ability to invest in new product ideas where innovation makes the difference. And with a management team with extensive experience in the medical device industry, Clinical Innovations possesses the working knowledge to develop those new product ideas into industry-changing specialty devices. Clinical Innovations is dedicated to quality and customer service. With ISO13485 certification and strong relationships with top worldwide medical distributors, Clinical Innovations has the systems and infrastructure in place to promptly respond to market trends and customer suggestions. Clinical Innovations is a Prizker Group Company.

Cogentix Medical

Acquisition in 2018
Cogentix Medical products have increased treatment efficiency and lowered patient risk. Macroplastique® established the European market for bulking agents, EndoSheath® protective barrier redefined endoscopy and Urgent® PC set the standard for percutaneous tibial nerve stimulation (PTNS) as a treatment for Overactive Bladder. Cogentix Medical was formed in 2015 following a merger of Uroplasty and Vision-Sciences.

Andromeda

Acquisition in 2017
ANDROMEDA medizin Systeme GmbH was founded in 1994. ANDROMEDA develops and markets modern and high-quality Urodynamic instruments. As a specialist and pioneer, the company is now one of the world's leading manufacturers of urodynamics.

iTind

Funding Round in 2016
Medi-Tate Ltd. is an Israeli medical device company focused on enhancing men's healthcare through innovative solutions. The company manufactures and sells iTIND, a temporarily implanted nitinol device designed to treat benign prostatic hyperplasia (BPH). This device offers long-lasting relief from BPH symptoms via a short, non-surgical procedure, marking a significant advancement in the management of this condition. iTIND is currently CE Marked, allowing it to be sold within the European Union. Founded in 2007 and based in Or Akiva, Israel, Medi-Tate aims to improve the quality of life for men by providing effective, office-based procedures for BPH treatment.

Medical Measurement Systems

Acquisition in 2015
Medical Measurement Systems engages in Gastrointestinal Diagnostics and Urodynamics. Medical Measurement Systems offers Uroflowmetry, a screening procedure to calculate the amount of urine; Urodynamics, which investigates the function of the lower urinary tract.

Unisensor

Acquisition in 2014
Unisensor is a manufacturer of medical-use sensors and catheters. They develop and manufacture measurement, multipoint catheters, pressure, ph, and transurethral and anorectal measurement catheters for use in urology. They also develop the compartment system measuring system for the diagnosis and therapy of muscle compartment syndrome.

BUCK Elektromedizin GmbH

Acquisition in 2014
As medical technology company, we specialize in therapy, diagnostic equipment and supply of EMG -home biofeedback, electrical stimulation and combination systems for applications in incontinence - and pain therapy area for the diagnosis and rehabilitation medicine (gynecology, urology, Coloproctology, neurology, speech therapy) , the clinical psychological treatment, as well as urodynamic, anorectal measuring stations and makeshift medical.

Mediwatch

Acquisition in 2013
Mediwatch is a manufacturer and distributor of urology and GI diagnostic products, including Urodynamics systems and disposables, Bladder Scanners, Uroflowmeters, Pelvic Floor Biofeedback equipment, Anorectal Manometry Systems, and PSA Test equipment and disposables.

UroMed Technology - Pelvic Muscle Rehabilitation Business

Acquisition in 2013
UroMed Technology - Pelvic Muscle Rehabilitation Business is a provider of pelvic muscle rehabilitation services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.